Ganga Pharmaceuticals Limited Share Price

Ganga Pharmaceuticals Limited Share Price

BSE: 539680
|
Pharmaceuticals

₹ 12.50

+0.00 (0.00%)
1D
Last updated 08 Sep, 2026, 13:46 IST
--
0.00% up today
--
1D LOW
1D HIGH

Ganga Pharmaceuticals Limited Returns Calculator

Volume
--
Average traded price
--
Last traded time
01:46:01 08 Sep
Last traded quantity
8,000
Circuit
L
H
₹10.00
₹15.00
52-week
L
H
₹9.35
₹13.97
Mkt Cap Cr
7.39
ROA
1.06%
ROE
1.3%
ROCE
2.9%
Quick Ratio
5.18
Based on fundamentals, this stock's
Step 5 of 5
Performance
Excellent
Ganga Pharma. outperforming all market indices
Step 3 of 5
Valuation
Fairly Valued
Ganga Pharma. appears to be fairly valued compared to its peers
Step 1 of 5
Earnings
Very Poor
Ganga Pharma. revenue, operating profits and net profits have been degrowing
Peer Comparison
Peer comparison — key ratios
NameMkt Cap CrROAROEROCEQuick Ratio
Sun Pharmaceutical Industries4,22,067.0111.19%13.74%17.33%2.31
Divis Laboratories2,48,982.9814.6%15.32%19.56%3.5
Torrent Pharmaceuticals1,77,251.424.87%25.49%13.85%0.75
Zydus Lifesciences1,13,615.698.57%18.59%17.35%0.91
Laurus Labs1,11,898.6610.38%16.77%16.14%0.68
Cipla1,06,129.967.92%11.27%14.95%2.5
Dr. Reddy's Laboratories1,02,707.415.48%11.07%12.54%1.35
Mankind Pharma99,089.527.36%11.74%13.13%0.74
Aurobindo Pharma97,972.476.34%9.25%11.76%1.15
Lupin89,628.8314.47%23.76%24.88%1.42

Auto-generated based on historical fundamentals; not a recommendation to buy/sell.

About Ganga Pharmaceuticals Limited

Ganga Pharmaceuticals Limited Share Price
ISIN
INE615T01017
Sector Market Cap
₹ 7.39 Cr

Ganga Pharmaceuticals Limited is an India-based company. The Company is engaged in the production of ayurvedic medicine. Apart from manufacturing, the Company is also into marketing and distribution of ayurvedic medicines. It offers ayurvedic medicines for acidity, antidandruff, antioxidants, blood purifier and skin disorder, constipation, cough and cold, dental care, diarrhea, ear care, female tonic, hair care, hemorrhoids and piles, indigestion, iron tonic, joint pains, kidney stone, liver disorder, rejuvenation tonic, sleep inducers, and offers herbal cosmetics. Its products include Asuka tablets, Dendroil, Ashwo tablets-tonic for body and mind; Raktaj tablets/syrup for skin disorders; Nirmalaya that relieves constipation; Khadira tablets (80 mg.) that relieves cough; Danta Doshahar Manjan for gum and teeth protective; Holetrica capsule that checks diarrhea and corrects digestion; Karnaraj drops ear drops, Femoherb syrup/tablets, and Mahabhrungraj oil.

Ganga Pharmaceuticals Limited Financial Highlights

  • Revenue: Ganga Pharmaceuticals Limited reported revenue of ₹2.62 crore in FY21 vs ₹3.25 crore in FY20. It showed a decrease of 19.38% on a yearly basis.
  • Operating Profit: Ganga Pharmaceuticals Limited reported an operating profit of ₹0.04 crore in FY21 vs ₹0.26 crore in FY20. It showed a decrease of 84.62% on a year-on-year basis.
  • Net Profit: Ganga Pharmaceuticals Limited reported a net profit of ₹0.02 crore in FY21 vs ₹0.19 crore in FY20. It showed a decrease of 89.47% on a yearly basis.
Know more
Promoters
50.91%
FII
0.00%
Other DII
0.00%
Retail and other
49.09%
Mutual funds
0.00%
Foreign Institutional Investor (FII)
FII shareholding by period
Jun 20250.00%
Jul 20250.00%
Sep 20250.00%
Mar 20260.00%
1 day
--
1 week
--
1 month
--
1 year
--
3 years
--
5 years
--
Day
Open / Close
Change %
08 Sep 26
₹12.00 / ₹12.50
+4.17%
12 Feb 26
₹12.00 / ₹12.00
0.00%
23 Jan 26
₹12.00 / ₹12.00
-14.10%
22 Jan 26
₹13.97 / ₹13.97
+18.39%
Show more

Ganga Pharmaceuticals Limited Financials

Full statement

Income Statement · Consolidated

Income Statement · Consolidated — all values in INR Crore
ParticularsMar 2020Mar 2021
Revenue3.252.62
Operating profit0.260.04
Net profit0.190.02

Income Statement · Standalone

Income Statement · Standalone — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Revenue₹2.83₹2.64₹2.74₹2.59
Other Income₹0.28₹0.44₹0.24₹0.30
Total Revenue₹3.11₹3.07₹2.98₹2.88
Total Expenses₹2.98₹2.98₹2.91₹2.83
Profit Before Tax₹0.13₹0.09₹0.06₹0.05
Tax₹0.03₹0.02₹0.02₹0.01
Profit After Tax₹0.10₹0.08₹0.05₹0.04
EPS - Basic₹0.17₹0.16₹0.11₹0.10
EPS - Diluted₹0.17₹0.12₹0.07₹0.10

Cash Flow · Standalone

Cash Flow · Standalone — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Profit before tax₹0.13₹0.09₹0.06₹0.05
Income before WC changes₹0.03-₹0.13₹0.05₹0.00
Change in Assets-₹0.94-₹0.84-₹0.60-₹0.23
Change in Liabilities-₹0.37₹0.41-₹0.70₹0.21
Change in WC-₹1.31-₹0.44-₹1.30-₹0.02
Cash flow from Operations-₹1.31-₹0.58-₹1.26-₹0.04
Cash flow from Investing₹0.24₹1.18₹0.13₹0.49
Cash flow from Financing₹0.82-₹0.33₹1.14-₹0.44
Total Cash Flow-₹0.24₹0.27₹0.00₹0.01
Cash (Start of the year)₹0.30₹0.03₹0.03₹0.02
Cash (End of the year)₹0.06₹0.30₹0.03₹0.03

Balance Sheet · Standalone

Balance Sheet · Standalone — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Non-Current Assets₹2.08₹2.11₹2.90₹2.84
Current Assets₹7.56₹6.87₹5.75₹5.15
Total Assets₹9.65₹8.97₹8.65₹7.98
Current Liabilities₹1.24₹1.60₹1.20₹1.89
Net Current Asset₹6.33₹5.26₹4.55₹3.25
Non-Current Liabilities₹0.10₹0.24₹0.40₹0.64
Equity Capital₹8.31₹7.13₹7.05₹5.45
Total Equity & Liabilities₹9.65₹8.97₹8.65₹7.98
* All values are in INR Crore
Qty
Bid
0
0
0
0
0
0
0
0
0
0
Ask
Qty
0
0
0
0
0
0
0
0
0
0
Bid Total: 0
Ask Total: 0
Buy orders: 0%
Sell orders: 0%
Bearish
2
Neutral
1
Bullish
1
Neutral
by SEBI experts
Expert Pick
EXPPICK
Stop-loss
Entry price
Target
Indicator
Value
Verdict
ATR (14)
0
Bullish
STOCH(9,6)
100
Bearish
ROC(12)
0
Neutral
WillR(14)
0
Bearish
Period
Simple value
Exponential vaue
5D
12.45
12.5
10D
12.33
0
20D
12.33
0
50D
12.33
0
100D
12.33
0

Technical indicators used here are for indicative purposes only. Kindly do not treat it as an investment or trading advice

Compare against other stocks
Ganga Pharmaceuticals Limited Share Price
Ganga Pharmaceuticals Limited
Pharmaceuticals
Add Stock
Add Another

Ganga Pharmaceuticals Limited Share Price FAQs

Disclaimer: The information on this page, including prices, charts, financials, ratios, and other data, is provided for informational and educational purposes only. It is not investment advice, a research report, or a recommendation or solicitation to buy, sell, or hold any security. Data is sourced from third parties and exchanges, may be delayed, and is not guaranteed to be accurate, complete, or timely. Upstox is not liable for any loss arising from its use.